Table 3.

The number (%) of patients with NP events and their attribution at each study assessment over 7 years.

VisitSLE NP, n (%)NP-positiveTotal, n (%)NP-negative, n (%)Total no. Patients
Non-SLE NP, n (%)SLE and Non-SLE, n (%)
113 (6.2)56 (26.8)13 (6.2)82 (39.2)127 (60.8)209
217 (9.4)50 (27.6)10 (5.5)77 (42.5)104 (57.5)181
313 (8.8)45 (30.6)12 (8.2)70 (47.6)77 (52.4)147
412 (10.5)34 (29.8)10 (8.8)56 (49.1)58 (50.9)114
59 (9.7)27 (29.0)8 (8.6)44 (47.3)49 (52.7)93
67 (9.3)23 (30.7)7 (9.3)37 (49.3)38 (50.7)75
75 (9.8)12 (23.5)3 (5.9)20 (39.2)31 (60.8)51
82 (9.1)2 (9.1)1 (4.6)5 (22.7)17 (77.3)22